Sustained release dosage forms of ziprasidone

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 9/28 (2006.01)

Patent

CA 2537413

A sustained release solid oral dosage from for treatment of a psychotic disorder, for example schizophrenia, in a mammal is provided, which oral dosage from comprises ziprasidone in an amount effective in treating said psychotic disorder and a pharmaceutically acceptable carrier.

L'invention concerne une forme posologique orale, solide, à libération prolongée destinée au traitement d'un trouble psychotique, par exemple la schizophrénie, chez un mammifère, ladite forme posologique orale comprenant de la ziprasidone en une quantité efficace pour traiter ledit trouble psychotique, ainsi qu'un support pharmaceutiquement acceptable.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Sustained release dosage forms of ziprasidone does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release dosage forms of ziprasidone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release dosage forms of ziprasidone will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1674384

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.